IMMUNITYBIO INC (IBRX) Stock Earnings & Estimates
NASDAQ:IBRX - US45256X1037 - Common Stock
2.355 USD
+0.02 (+0.64%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 240K -74.19% | 622K 159.17% | 14.745M 2,270.58% | 107.63M 629.94% | 225.93M 109.91% | 565.7M 150.39% | 1.007B 78.01% | 1.995B 98.11% | 3.499B 75.39% | 6.704B 91.60% | 9.441B 40.83% | |
| EBITDA YoY % growth | -332.36M -5.16% | -342.852M -3.16% | -326.628M 4.73% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -350.62M -6.16% | -361.364M -3.06% | -344.182M 4.75% | -286.42M 16.78% | -251.564M 12.17% | 20.186M 108.02% | 420.74M 1,984.32% | 1.302B 209.45% | 2.622B 101.38% | 5.464B 108.39% | 7.877B 44.16% | |
| Operating Margin | -146,091.67% | -58,097.11% | -2,334.23% | -266.11% | -111.35% | 3.57% | 41.78% | 65.26% | 74.94% | 81.50% | 83.43% | |
| EPS YoY % growth | -1.05 -17.98% | -1.13 -7.62% | -0.61 46.02% | -0.53 13.89% | -0.36 30.87% | -0.06 83.15% | 0.36 691.67% | 1.18 226.76% | 2.45 106.90% | 5.13 109.38% | 7.02 37.01% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.11 8.20% | -0.12 -29.20% | -0.11 25.20% | -0.11 -12.20% | -0.11 -1.85% | -0.12 -5.26% |
| Revenue Q2Q % growth | 32.518M 432.56% | 35.986M 376.51% | 30.6M 85.26% | 33.15M 25.45% | 37.658M 15.81% | 42.238M 17.37% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -71.178M 11.31% | -76.811M -10.68% | -72.165M -12.01% | -77.329M -8.48% | -78.028M -9.62% | -81.22M -5.74% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.10 50.00% | -0.11 | 0.01 | 10.87% |
| Q1 2025 Q2Q % growth | -0.15 25.00% | -0.13 | -0.02 | -14.89% |
| Q4 2024 Q2Q % growth | -0.09 74.29% | -0.20 | 0.11 | 55.88% |
| Q3 2024 Q2Q % growth | -0.12 36.84% | -0.18 | 0.06 | 34.64% |
| Q2 2024 Q2Q % growth | -0.20 37.50% | -0.17 | -0.03 | -15.34% |
| Q1 2024 Q2Q % growth | -0.20 25.93% | -0.16 | -0.04 | -22.55% |
| Q4 2023 Q2Q % growth | -0.35 -29.63% | -0.18 | -0.17 | -90.63% |
| Q3 2023 Q2Q % growth | -0.19 32.14% | -0.26 | 0.07 | 26.95% |
| Q2 2023 Q2Q % growth | -0.32 -33.33% | -0.24 | -0.08 | -33.50% |
| Q1 2023 Q2Q % growth | -0.27 -3.85% | -0.28 | 0.01 | 1.96% |
| Q4 2022 Q2Q % growth | -0.27 -17.39% | -0.22 | -0.05 | -20.32% |
| Q3 2022 Q2Q % growth | -0.28 -27.27% | -0.23 | -0.05 | -19.35% |
| Q2 2022 Q2Q % growth | -0.24 -4.35% | -0.24 | 0.00 | 1.96% |
| Q1 2022 Q2Q % growth | -0.26 -23.81% | -0.22 | -0.04 | -15.86% |
| Q4 2021 Q2Q % growth | -0.23 23.33% | -0.21 | -0.02 | -7.38% |
| Q3 2021 Q2Q % growth | -0.22 -10.00% | -0.20 | -0.02 | -7.84% |
| Q2 2021 Q2Q % growth | -0.23 -15.00% | -0.12 | -0.11 | -87.91% |
| Q1 2021 Q2Q % growth | -0.21 -10.53% | -0.42 | 0.21 | 49.78% |
| Q4 2020 Q2Q % growth | -0.30 -87.50% | -0.18 | -0.12 | -63.40% |
| Q3 2020 Q2Q % growth | -0.20 -25.00% | -0.18 | -0.02 | -8.93% |
| Q2 2020 Q2Q % growth | -0.20 -17.65% | -0.19 | -0.01 | -3.20% |
| Q1 2020 Q2Q % growth | -0.19 13.64% | -0.17 | -0.02 | -9.57% |
| Q4 2019 Q2Q % growth | -0.16 | -0.20 | 0.04 | 21.57% |
| Q3 2019 Q2Q % growth | -0.16 | -0.19 | 0.03 | 13.81% |
| Q2 2019 Q2Q % growth | -0.17 | -0.25 | 0.08 | 30.70% |
| Q1 2019 Q2Q % growth | -0.22 | -0.24 | 0.02 | 8.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 26.425M 2,423.88% | 23.223M | 3.202M | 13.79% |
| Q1 2025 Q2Q % growth | 16.517M 41,192.50% | 16.335M | 182K | 1.11% |
| Q4 2024 Q2Q % growth | 7.552M 5,333.09% | 7.973M | -421K | -5.28% |
| Q3 2024 Q2Q % growth | 6.106M 7,346.34% | 2.985M | 3.121M | 104.56% |
| Q2 2024 Q2Q % growth | 1.047M 2,453.66% | 2.57M | -1.523M | -59.26% |
| Q1 2024 Q2Q % growth | 40K -88.89% | 25.5K | 14.5K | 56.86% |
| Q4 2023 Q2Q % growth | 139K 98.57% | 25.5K | 113.5K | 445.10% |
| Q3 2023 Q2Q % growth | 82K -31.67% | 25.5K | 56.5K | 221.57% |
| Q2 2023 Q2Q % growth | 41K 2.50% | 25.5K | 15.5K | 60.78% |
| Q1 2023 Q2Q % growth | 360K 3,500.00% | 25.5K | 334.5K | 1,311.76% |
| Q4 2022 Q2Q % growth | 70K -82.05% | 25.5K | 44.5K | 174.51% |
| Q3 2022 Q2Q % growth | 120K 71.43% | 25.5K | 94.5K | 370.59% |
| Q2 2022 Q2Q % growth | 40K -88.24% | 25.5K | 14.5K | 56.86% |
| Q1 2022 Q2Q % growth | 10K -92.86% | 25.5K | -15.5K | -60.78% |
| Q4 2021 Q2Q % growth | 390K 360.00% | 25.5K | 364.5K | 1,429.41% |
| Q3 2021 Q2Q % growth | 70K -53.33% | 25.5K | 44.5K | 174.51% |
| Q2 2021 Q2Q % growth | 340K -22.73% | 25.5K | 314.5K | 1,233.33% |
| Q1 2021 Q2Q % growth | 140K -17.65% | 25.5K | 114.5K | 449.02% |
| Q4 2020 Q2Q % growth | -150K -106.91% | 15.3K | -165.3K | -1,080.39% |
| Q3 2020 Q2Q % growth | 150K 1,400.00% | 7.65K | 142.35K | 1,860.78% |
| Q2 2020 Q2Q % growth | 440K 2,100.00% | 7.65K | 432.35K | 5,651.63% |
| Q1 2020 Q2Q % growth | 170K 1,600.00% | 170K | % | |
| Q1 2019 Q2Q % growth | 10K | 3.57K | 6.43K | 180.11% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.82% | -197.3% | -9.11% | -5.1% |
| Revenue | 15.3% | -13.39% | 9.28% | 7.5% |